PubMed ID:
21148246
Public Release Type:
Journal
Publication Year: 2011
Affiliation: Department of Medicine, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA.
DOI:
https://doi.org/10.2215/CJN.04620510
Authors:
Brunelli SM,
Curhan GC,
Lynch KE,
Lynch R
Request IDs:
1389
Studies:
Hemodialysis Study
Hyperphosphatemia is common among hemodialysis patients. Although prescribed dietary phosphate restriction is a recommended therapy, little is known about the long-term effects on survival.